CU Cell Therapy Trial Shows Results in Treating Progressive Multiple Sclerosis

The lab of Angelo D’Alessandro, PhD, a professor at the CU School of Medicine, had already been working with Cambridge to understand the metabolic support of neurodegeneration in multiple sclerosis, with a special focus on the role of metabolic signals driving inflammatory events that make immune cells in the brain turn against neurons.